BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cyberonics Inc. 

Cyberonics Building
100 Cyberonics Boulevard
Houston  Texas  77058  U.S.A.
Phone: 281-228-7200 Fax: 281-218-9332


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Medical Device






 Company News
Cyberonics Inc. (CYBX) To Participate In Upcoming Investor Conferences 8/22/2014 7:53:41 AM
Cyberonics Inc. (CYBX) Reports Fiscal 2015 First Quarter Results 8/21/2014 8:04:51 AM
Cyberonics Inc. (CYBX) To Report Fiscal Year 2015 First Quarter Results And Host Webcast And Conference Call On August 21, 2014 8/7/2014 10:04:54 AM
Cyberonics Inc. (CYBX) Release: ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 6/25/2014 9:33:29 AM
Cyberonics Inc. (CYBX) Reports Record Quarter And Annual Results And Provides Fiscal 2015 Guidance 6/4/2014 6:45:24 AM
Cyberonics Inc. (CYBX) To Present At The William Blair 34th Annual Growth Stock Conference 5/28/2014 7:46:10 AM
Cyberonics Inc. (CYBX) To Report Fourth Quarter And Fiscal Year 2014 Results And Host Webcast And Conference Call On June 4, 2014 5/21/2014 8:10:00 AM
Cyberonics Inc. (CYBX) Announces Peer-Reviewed Publication Of VNS Therapy® Long-Term Comparative Effectiveness Study In Patients With Refractory Epilepsy 5/6/2014 9:43:36 AM
Cyberonics Inc. (CYBX) Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer 4/28/2014 8:48:39 AM
Cyberonics Inc. (CYBX) Announces CE Mark Approval Of The AspireSR™ Generator For VNS Therapy® 2/20/2014 6:59:54 AM
12345678910...